论文部分内容阅读
目的 重型肝炎发病急,合并症多,病死率高。目前尚无特效治疗药物。探索有效的治疗方法仍是当务之急。方法 我们在综合治疗的基础上使用抗病毒药物可耐(膦甲酸钠)注射液2.4g,1日2次静脉滴注,保肝降酶药甘利欣40mL,1日1次静脉滴注,治疗重型肝炎20例,1月后统计结果。结果 有效14例(70％);无效6例(30％);对照组18例,有效9例(50％),无效9例(50％),两组比较有显著性差异(P<0.05)。结论 可耐、甘利欣联合治疗重症肝炎效果好,值得推广。
Purpose The incidence of severe hepatitis, acute complications, high mortality. There is no effective treatment. Exploring effective treatments is still a top priority. Methods We used antiviral drugs resistant (foscarnet) injection 2.4g on the basis of comprehensive treatment, 2 times on the 1st intravenous drip, liver protection enzyme Ganulixin 40mL, 1 on the 1st intravenous infusion, the treatment of heavy Hepatitis 20 cases, statistics after January. Results were effective in 14 cases (70%), ineffective in 6 cases (30%), control group (18 cases), effective in 9 cases (50%) and ineffective in 9 cases (50%). There was significant difference between the two groups (P < . Conclusions resistant, Gan Lixin combined treatment of severe hepatitis effective, it is worth promoting.